SP600125 | MedChemExpress (MCE)

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SP600125

CAS No. : 129-56-6

MCE 国际站：SP600125

产品活性：SP600125 是一种口服有效的，可逆的，ATP竞争性的 JNK 抑制剂，抑制 JNK1， JNK2 和 JNK3 的 IC₅₀ 分别为 40，40，90 nM。SP600125 是一种有效的铁死亡 (ferroptosis) 抑制剂。SP600125 能诱导膀胱癌细胞自噬 (autophagy) 向凋亡 (apoptosis) 的转化。

研究领域：MAPK/ERK Pathway  |  Autophagy  |  Apoptosis

作用靶点：JNK  |  Autophagy  |  Apoptosis  |  Ferroptosis

In Vitro: SP600125 is an ATP-competitive inhibitor of JNK2 with a K_i value of 0.19±0.06 μM. SP600125 inhibits the phosphorylation of c-Jun with IC₅₀ of 5 μM to 10 μM in Jurkat T cells. In CD4⁺ cells, such as Th0 cells isolated from either human cord or peripheral blood, SP600125 blocks cell activation and differentiation and inhibits the expression of inflammatory genes COX-2, IL-2, IL-10, IFN-γ, and TNF-α, with IC₅₀ of 5 μM to 12 μM.
In a mouse beta cells MIN6, SP600125 (20 μM) induces the phosphorylation of p38 MAPK and its downstream CREB-dependent promoter activation.
In HCT116 cells, SP600125 (20 μM) blocks the G2 phase to mitosis transition and induces endoreplication. This ability of SP600125 is independent of JNK inhibition, but due to its inhibition of CDK1-cyclin B activation upstream of Aurora A and Polo-like kinase 1.

In Vivo: Administration of SP600125 at 15 or 30 mg/kg i.v. significantly inhibits TNF-α serum levels, whereas oral administration dose-dependently blocks TNF-α expression with significant inhibition observed at 30 mg/kg per os.
SP600125 attenuates LPS-induced ALI in rats in vivo. The expression levels of TNF-α and IL-6 in the BALF in rats in the SP600125 group are significantly decreased.

相关产品：Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Immunology/Inflammation Compound Library  |  Kinase Inhibitor Library  |  MAPK Compound Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Reprogramming Compound Library  |  Oxygen Sensing Compound Library  |  Ferroptosis Compound Library  |  Orally Active Compound Library  |  Anti-Parkinson's Disease Compound Library  |  Anti-Obesity Compound Library  |  Transcription Factor-Targeted Library  |  Antidepressant Compound Library  |  Human Metabolite Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Heterocyclic Compound Library  |  Pain-Related Compound Library  |  Mitochondrial Toxicity Compound Library  |  Cell Death Library  |  Serine/Threonine Kinase Inhibitor Library  |  Multi-Target Compound Library  |  MG-132  |  Ferrostatin-1  |  Erastin  |  Cisplatin  |  Cycloheximide  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  RSL3  |  Tamoxifen  |  Y-27632  |  LY294002  |  Paclitaxel  |  Acetylcysteine  |  Angiotensin II human  |  2-Deoxy-D-glucose  |  Staurosporine  |  Actinomycin D  |  SB-431542  |  5-Fluorouracil  |  Bortezomib  |  Deferoxamine mesylate  |  Oxaliplatin  |  Trametinib  |  ML385  |  Sorafenib  |  Necrostatin-1  |  Temozolomide  |  Gemcitabine  |  Decitabine  |  Mdivi-1

热门产品线：重组蛋白  |  药物筛选  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。